( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
Welcome to St. Germain, Wisconsin, where hidden treasures await at every turn! If you’re a fan of unique finds and nostalgic knick-knacks, boy, do we have a treat for you. Nestled in the heart of the ...